| “Zero C” hospital project: an innovative screening and referral model in hospitalized patients at different divisions V Rosato, L Kondili, R Nevola, A Aghemo, P Perillo, R Napolitano, ... Journal of Hepatology 77, S212, 2022 | | 2022 |
| 1008 SUSTAINED VIROLOGIC RESPONSE TO INTERFERON PREVENTS THE LETHAL CONSEQUENCE OF CLINICAL DECOMPENSATION IN PATIENTS WHO DEVELOP A HEPATOCELLULAR CARCINOMA POST ANTIVIRAL … S Bruno, M Iavarone, M Vigano, A Crosignani, S Rossi, A Aghemo, ... Journal of Hepatology, S394, 2012 | | 2012 |
| 1065 COMBINED TRANSIENT ELASTOGRAPHY OF THE LIVER AND SPLEEN TO ASSESS DISEASE SEVERITY IN CHRONIC VIRAL LIVER DISEASE R Pozzi, M Fraquelli, M Giunta, C Rigamonti, S Della Valle, S Massironi, ... Journal of Hepatology, S419, 2012 | | 2012 |
| 1080 LOW RATES OF SVR TO PEGINTERFERON PLUS RIBAVIRIN IN HCV GENOTYPE 1 IL28B RS12979860 CC CIRRHOTIC PATIENTS WITHOUT RAPID VIROLOGICAL RESPONSE E Degasperi, A Aghemo, E Galmozzi, L Valenti, MG Rumi, ... Journal of Hepatology, S425, 2012 | | 2012 |
| 1148 THE PRESENCE OF HEPATITIS C VIRUS DELETION MUTANTS IN CHRONIC HEPATITIS C PATIENTS AND THEIR ROLE DURING PEG-IFN/RIBAVIRIN THERAPY IN HCV-1 PATIENTS L Donnici, C Cheroni, A Aghemo, MG Rump, V Valveri, R Soffredini, ... Journal of Hepatology, S453-S454, 2011 | | 2011 |
| 12 weeks ombitasvir/paritaprevir–ritonavir+ ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis E Degasperi, A Aghemo, S Paolucci, R D’Ambrosio, M Borghi, ... Digestive and Liver Disease 50 (7), 703-706, 2018 | | 2018 |
| 1318 fibrosis progression in patients with chronic hepatitis C is not influenced by IL28B polymorphisms A Aghemo, F Marabita, S De Nicola, MG Rumi, C Cheroni, R Scavelli, ... Journal of Hepatology, S519, 2011 | 5 | 2011 |
| 229 NATURAL HISTORY AND MULTIMODALITY TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA PROSPECTIVELY DETECTED IN CIRRHOTIC PATIENTS UNDER SURVEILLANCE A Sangiovanni, C Della Corte, MA Manini, S Vavassori, M Iavarone, ... Journal of Hepatology, S97, 2010 | | 2010 |
| 291 INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY GM Prati, MG Rumi, A Aghemo, R D'Ambrosio, S De Nicola, L Olgiati, ... Journal of Hepatology, S122, 2010 | 4 | 2010 |
| 303 EARLY ACTIVATION OF EFFECTOR CYTOTOXIC NK CELLS PREDICTS SUCCESSFUL TREATMENT OUTCOME IN CHRONIC HCV INFECTION B Oliviero, D Mele, E Degasperi, E Cremonesi, S Varchetta, A Aghemo, ... Journal of Hepatology, S123, 2011 | | 2011 |
| 31 Salivary glands impairment during interferon/ribavirin treatment in patients with chronic hepatitis C A Aghemo, V Cuccarini, MG Rumi, M Paglia, F Ottaviani, E Del Ninno, ... Digestive and Liver Disease, A18, 2003 | | 2003 |
| 35 THE NATURAL HISTORY OF HEPATIC MACROREGENERATIVE NODULES DEVELOPING IN CIRRHOTIC PATIENTS DURING SURVEILLANCE WITH ULTRASOUND (US) A Sangiovanni, C Della Corte, MA Manini, M Iavarone, S Vavassori, ... Digestive and Liver Disease, S14, 2010 | | 2010 |
| 425 il28b genotype in hdv chronic patients correlates with unfavourable outcome but not with response to ifn treatment R Romeo, AM Aghemo, G Casazza, E Galmozzi, M Manini, E De Gasperi, ... Journal of Hepatology, S174, 2013 | 1 | 2013 |
| 448 IL28B GENOTYPE IS NOT ASSOCIATED WITH INSULIN RESISTANCE IN CHRONIC HEPATITIS C PATIENTS E Degasperi, L Valenti, A Aghemo, R De Francesco, R Soffredini, ... Journal of Hepatology, S183, 2013 | | 2013 |
| 46 IMMUNOLOGICAL PROFILES OF NON-RESPONDER AND RELAPSER PATIENTS WITH CHRONIC HCV INFECTION TREATED WITH STANDARD OF CARE THERAPY B Oliviero, D Mele, E Degasperi, S Varchetta, A Aghemo, MG Rumi, ... Journal of Hepatology, S20, 2012 | | 2012 |
| 506 UNDETECTABLE HCV-RNA IN TELAPREVIR-TREATED PATIENTS: LOW CONCORDANCE BETWEEN TWO HIGHLY SENSITIVE REAL-TIME PCR ASSAYS J Vermehren, A Aghemo, KH Peiffer, S Susser, R D'Ambrosio, D Perner, ... Journal of Hepatology, S208, 2013 | 3 | 2013 |
| 769 GENOTYPE DEPENDENT PATTERN OF PEGINTERFERON ALFA-2B/RIBAVIRIN TREATMENT FAILURE IN HEPATITIS C VIRUS INFECTED PATIENTS WITH CIRRHOSIS: A SINGLE CENTER STUDY OF 471 NAIVE … A Aghemo, MG Rumi, S Monico, GM Prati, G Ronchi, M Colombo Journal of Hepatology, S287, 2008 | | 2008 |
| 934 DIFFERENCES IN HCV GENOTYPE 1 RVR RATES AMONG CLINICAL TRIALS IN EUROPE DEPEND ON HCV RNA ASSAY SENSITIVITY J Vermehren, A Aghemo, S Süsser, TM Scherzer, MG Rumi, M Colombo, ... Journal of Hepatology, S364, 2012 | 3 | 2012 |
| 975 Salivary glands impairment in patients with chronic hepatitis C undergoing PEG-interferon/ribavirin treatment AM Aghemo, MG Rumi, V Cuccarini, M Paglia, F Ottaviani, E Del Ninno, ... Hepatology, 625, 2003 | | 2003 |
| A ‘multiomic’approach of saliva metabolomics, microbiota, and serum biomarkers to assess the need of hospitalization in coronavirus disease 2019 C Pozzi, R Levi, D Braga, F Carli, A Darwich, I Spadoni, B Oresta, ... Gastro Hep Advances 1 (2), 194-209, 2022 | 13 | 2022 |
